Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
74.52
+0.11 (0.15%)
At close: Jun 12, 2026, 4:00 PM EDT
74.51
-0.01 (-0.01%)
After-hours: Jun 12, 2026, 6:35 PM EDT
Arrowhead Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Arrowhead Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $88.17. The average 1-year stock price forecast is 18.32% higher than the current stock price, while the lowest is $46 (-38.27%) and the highest is $110 (+47.61%).
Price Target: $88.17 (+18.32%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Arrowhead Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 3 | 4 | 4 |
| Hold | 4 | 3 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 12 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $100 | Buy | Reiterates | $100 | +34.19% | Jun 4, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $100 | Buy | Maintains | $100 | +34.19% | May 27, 2026 |
| Bernstein | Bernstein | Hold Reiterates $35 → $46 | Hold | Reiterates | $35 → $46 | -38.27% | May 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $110 | Buy | Reiterates | $110 | +47.61% | May 8, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $87 | Buy | Maintains | $87 | +16.75% | May 8, 2026 |
Financial Forecast
Revenue This Year
444.11M
from 829.45M
Decreased by -46.46%
Revenue Next Year
336.76M
from 444.11M
Decreased by -24.17%
EPS This Year
-3.00
from -0.01
EPS Next Year
-4.34
from -3.00
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 618.0M | ||
| Avg | 444.1M | ||
| Low | 340.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -25.5% | ||
| Avg | -46.5% | ||
| Low | -59.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.73 | ||
| Avg | -3.00 | ||
| Low | -3.82 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |